Sat.Dec 21, 2019 - Fri.Dec 27, 2019

article thumbnail

Are you a consensus leader or dictator?

Berkonomics

It’s a good bet that you’ve been exposed to articles, courses and lectures about various styles of management, and how each is appropriate for some companies and for some levels of organization and at various times. When should the dictator in you emerge? A consensus-building leader works well in that style until someone yells “fire!” and the emergency requires a dictatorial style of management to act quickly, protecting lives.

article thumbnail

Should Leaders Wait Until Monday Morning to Send Their Weekend Emails to Staff?

Entrepreneurs' Organization

Contributed by Stefano Maifreni, founder and director of Eggcelerate. We’ve all been there—working outside hours, trying to get ahead or catch up. But sending emails to staff during their downtime can backfire badly. And here’s why … In 2019, the average office worker received 90 emails per day. But it’s the occasional messages sent by bosses to their team members late at night or at weekends that can have negative consequences—particularly on your culture.

culture 260
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Chemistry Experiment: Recruiting A New Director

The Seraf Compass

In previous posts we have addressed how Board Directors can add value, communicate effectively with CEOs, and prepare for successful board meetings, but how should entrepreneurs go about recruiting one? A good Board Director can be a huge asset, but a bad one can actually be a hindrance to your business, and at the very least leave you lacking the skills and advice you need.

board 209
article thumbnail

Subscription Tracking

A VC: Musings of a VC in NYC

My brother in law Jerry is working on a project to collect all of his family’s digital subscriptions; subscriptions to streaming video services, music services, subscriptions to online news and other publications, subscriptions to software services, subscriptions to education services, etc, etc. He is planning a dinner in which he will review all of them with his family and understand which ones they are using and which ones they are not using.

education 117
article thumbnail

Digitalization: 5 Tech Updates That Will Help You Survive The Recession & Thrive

Lack of digitalization decreases business competitiveness. To thrive, embracing modern solutions becomes essential. The approach to digitalization often aligns with a company's business model. This shift not only boosts productivity but also automates processes and improves security. The tech market offers a wealth of technologies tailored for management, planning, and forecasting, replacing outdated pen-and-paper methods.

article thumbnail

Announcing the Startup School 2019 Grant Recipients

Y Combinator

As part of our efforts to further support founders in Startup School , we awarded $15,000 in equity-free grants to the most promising companies to go through the course. The quality (and quantity!) of founders who participated in Startup School this past year made the grant selection process a tough one. Congratulations to the following startups* for their impressive progress over the 10-weeks of Startup School!

startup 75

More Trending

article thumbnail

Focus on Progress Leadership Not Change Management

Entrepreneurs' Organization

Contributed by Dean Lindsay author of Creating Progress In A World Of Change , a keynote speaker and author of award-winning How to Achieve Big PHAT Goals. Just because a business or organization is getting bigger does not mean it is progressing. A serious challenge for businesses large and small is to progress —and not just change. The business term “change management” has been around for a good long while.

article thumbnail

Sickle cell disease treatment has roots in lab of OMRF’s Dr. Rodger McEver

Innovation 2 Enterprise

By Scott Meacham. There is very big news this month for individuals and families affected by sickle cell disease (SCD). The U.S. Food and Drug Administration (FDA) has approved the first targeted treatment to reduce the frequency of pain crises in individuals living with SCD. This new drug — Adakveo ® from Novartis — decreases the frequency of the debilitating and unpredictable pain episodes caused by SCD.

health 40
article thumbnail

Video Of The Week: Targeting Tech: Is Antitrust the Answer?

A VC: Musings of a VC in NYC

USV’s portfolio company Recount Media produces excellent short (5 mins or less) videos about political news and related topics. They also produce the Shift series of events. In November, Recount did a Shift event about Antitrust policy and my partner Brad Burnham was on the panel. This is a Recount style 5min summary of that conversation.

media 135
article thumbnail

[OurCrowd in Business Wire] OurCrowd, Perrigo and BOL Win the Israeli Government Tender for Operation of a Medical Cannabis Incubator in Yeruham

OurCrowd

-OurCrowd, the leading global investment platform and the most active venture capital investor in Israel, Perrigo, the world’s largest non-prescription drug company, and BOL Pharma, the leading medical cannabis company in Israel and an OurCrowd portfolio company, today announced that the consortium they established won the tender issued by the Israel Innovation Authority to operate CanNegev, a medical cannabis incubator which will be located in Yeruham in the south of Israel.

article thumbnail

The Big Payoff of Application Analytics

Outdated or absent analytics won’t cut it in today’s data-driven applications – not for your end users, your development team, or your business. That’s what drove the five companies in this e-book to change their approach to analytics. Download this e-book to learn about the unique problems each company faced and how they achieved huge returns beyond expectation by embedding analytics into applications.

article thumbnail

How To Build Product As A Small Startup

Y Combinator

Y Combinator CEO and Partner Michael Seibel shares a process for building product as a small startup. Topics. 00:00 – Have a process to get product out the door. 1:02 – Decide on a release schedule. 1:15 – Put someone in charge of product. 1:34 – Establish KPIs. 1:47 – Create a theme for the product cycle based on a KPI. 2:00 – Product meeting. 2:30 – Brainstorm new features, bugs, and tests. 3:35 – Sort each into: easy, medium, or hard. 4:59 ̵

startup 74
article thumbnail

Non-Obvious Megatrends 2020. Rohit Bhargava How To Read the Future

Smart Hustle Magazine

Rohit Bhargava is obsessed with understanding trends, past, present and future. His 10th and last edition of the Non-Obvious Trends reports is out on January 7th and from my review it's good. Listen to the interview and read more below! What I liked best was in fact the first part of the book, where Rohit shares how we can all learn to open our minds to see the future.

article thumbnail

Happy Birthday Ollie

A VC: Musings of a VC in NYC

Our dog Ollie is eleven today. Here is a photo of him on the beach with a tennis ball, pretty much his favorite place to be and thing to do.

134
134
article thumbnail

[OurCrowd in CTech] Israeli Small-Town Yeruham Gets Medical Cannabis Incubator

OurCrowd

Israeli small-town Yeruham is getting a medical cannabis incubator. Jerusalem-based equity crowdfunding company OurCrowd Ltd., pharmaceutical manufacturer Perrigo Company PLC, and Israel-based medical cannabis company Breath of Life International Ltd. (BOL Pharma) won a tender issued by the Israel Innovation Authority (IIA), the Israeli government’s tech investment arm, to operate an incubator in southern town Yeruham for a period of five years, IIA announced Monday.

article thumbnail

PE Mastery: CAPTARGET's Playbook for Quality Lead Flow

CAPTARGET presents a masterclass in M&A deal sourcing. Learn to cast a wide net, embracing seller self-identification. Consistency is the linchpin: keep the origination process steady for a reliable flow of opportunities. Diversify your tactics, employing various tools and vendors. Tech matters! Understand DNS settings, domain authority, and brand presence for optimal outreach.

article thumbnail

[Bol Pharma in CTech] Israeli Small-Town Yeruham Gets Medical Cannabis Incubator

OurCrowd

Israeli small-town Yeruham is getting a medical cannabis incubator. Jerusalem-based equity crowdfunding company OurCrowd Ltd., pharmaceutical manufacturer Perrigo Company PLC, and Israel-based medical cannabis company Breath of Life International Ltd. (BOL Pharma) won a tender issued by the Israel Innovation Authority (IIA), the Israeli government’s tech investment arm, to operate an incubator in southern town Yeruham for a period of five years, IIA announced Monday.

article thumbnail

[OurCrowd in The Jerusalem Post] Israel to accelerate medical cannabis research with hi-tech incubator

OurCrowd

Projecting an estimated investment of NIS 150 million into the small Negev town, the tender to operate the government-backed CanNegev incubator was awarded to crowdfunding investment platform OurCrowd, nonprescription pharmaceutical giant Perrigo and Israeli medical cannabis cultivator BOL Pharma. Read more here. The post [OurCrowd in The Jerusalem Post] Israel to accelerate medical cannabis research with hi-tech incubator appeared first on OurCrowd.

article thumbnail

[OurCrowd in Benzinga] OurCrowd, Perrigo and BOL Win the Israeli Government Tender for Operation of a Medical Cannabis Incubator in Yeruham

OurCrowd

OurCrowd, the leading global investment platform and the most active venture capital investor in Israel, Perrigo, the world’s largest non-prescription drug company, and BOL Pharma, the leading medical cannabis company in Israel and an OurCrowd portfolio company, today announced that the consortium they established won the tender issued by the Israel Innovation Authority to operate CanNegev, a medical cannabis incubator which will be located in Yeruham in the south of Israel.

article thumbnail

[OurCrowd in NoCamels] OurCrowd to Co-Run Government-Backed Medical Cannabis Incubator in Negev

OurCrowd

Jerusalem-based equity crowdfunding platform OurCrowd announced this week that a consortium it established in partnership with Perrigo, a private label over-the-counter pharmaceuticals manufacturer and BoL Pharma, one of the first licensed cannabis cultivators in Israel, has won a tender by the Israel Innovation Authority to operate the government-backed incubator, dubbed CanNegev.

article thumbnail

How to Stay Competitive in the Evolving State of Martech

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

article thumbnail

[OurCrowd in Crowdfund Insider] Global Crowdfunding Platform OurCrowd Receives Tender to Operate Medical Cannabis Incubator

OurCrowd

Leading global investment crowdfunding platform OurCrowd has received the tender to operate a medical cannabis incubator. OurCrowd is part of a consortium that won the tender including Perrigo, a non-prescription drug company, and BOL Pharma, a medical cannabis company in Israel and an OurCrowd portfolio company. Read more here. The post [OurCrowd in Crowdfund Insider] Global Crowdfunding Platform OurCrowd Receives Tender to Operate Medical Cannabis Incubator appeared first on OurCrowd.

article thumbnail

[OurCrowd in Haaretz] Israel to Get First State-sponsored Medical Marijuana Startup Incubator

OurCrowd

It will be managed by OurCrowd, an Israeli crowd-funded investment fund; Perrigo, the world’s largest over-the-counter pharma company; and BOL Pharma, an Israeli medical marijuana company. Read more here. The post [OurCrowd in Haaretz] Israel to Get First State-sponsored Medical Marijuana Startup Incubator appeared first on OurCrowd.

article thumbnail

[OurCrowd in The Jerusalem Post] OurCrowd, Perrigo & BOL Win Israeli Government Tender for Operation of a Medical Cannabis Incubator in Yeruham

OurCrowd

Projecting an estimated investment of NIS 150 million into the small Negev town, the tender to operate the government-backed CanNegev incubator was awarded to crowdfunding investment platform OurCrowd, nonprescription pharmaceutical giant Perrigo and Israeli medical cannabis cultivator BOL Pharma. Read more here. The post [OurCrowd in The Jerusalem Post] OurCrowd, Perrigo & BOL Win Israeli Government Tender for Operation of a Medical Cannabis Incubator in Yeruham appeared first on OurCrowd

article thumbnail

[OurCrowd in The Jerusalem Post] Israeli venture firm OurCrowd to run New Zealand start-up incubator

OurCrowd

This is the first time OurCrowd has won an international tender, and reflects the growing prestige and recognition of Israel’s investment platforms. Read more here. The post [OurCrowd in The Jerusalem Post] Israeli venture firm OurCrowd to run New Zealand start-up incubator appeared first on OurCrowd.

article thumbnail

Statement of Cash Flows vs. Cash Flow Statement

Speaker: Wayne Spivak - President and Chief Financial Officer of SBA * Consulting LTD, Industry Writer, and Public Speaker

The old adages that "cash is king" and "you can’t spend profits" still hold true today. But however well-known these sayings might be, it requires a change in mindset to properly implement a cash flow management system that predicts your business's runaway as accurately as possible. Key to this new mindset is understanding the difference between the Statement of Cash Flows, a historical look at the source and uses of cash, and the Cash Flow Statement, which uses transaction history and forward-l

article thumbnail

[OurCrowd in The Times of Israel] Sleepy southern Israel town seeks new highs with cannabis incubator plan

OurCrowd

The incubator will be run by Jerusalem based VC-fund OurCrowd, pharmaceutical maker Perrigo Co., and BOL Pharma, an Israeli medical cannabis firm. Read more here. The post [OurCrowd in The Times of Israel] Sleepy southern Israel town seeks new highs with cannabis incubator plan appeared first on OurCrowd.

article thumbnail

[OurCrowd in CTech] Double Investment, Double Impact

OurCrowd

According to a 2019 report published by the OurCrowd Foundation together with Social Finance Israel, this market is estimated at approximately $260 million a year, double the sum recorded in 2018. Read more here. The post [OurCrowd in CTech] Double Investment, Double Impact appeared first on OurCrowd.

article thumbnail

[Syqe in NoCamels] 2010-2019 Insights from a Decade of World-Changing Israeli Innovations

OurCrowd

In June, Syqe Medical, an Israeli pharma-tech company, announced the launch of the world’s first pharmaceutical-grade metered-dose cannabis inhaler. This drug delivery device will enable physicians to prescribe precise dosages meeting pharmaceutical standards. Read more here. The post [Syqe in NoCamels] 2010-2019 Insights from a Decade of World-Changing Israeli Innovations appeared first on OurCrowd.

article thumbnail

[Lemonade in CTech] These Are The Biggest Israeli Tech Funding Rounds We Reported on in 2019

OurCrowd

Lemonade offers customizable property and casualty insurance policies at a flat monthly rate in the U.S. Back in April, Lemonade said the investment will fund its upcoming European launch, and support further expansion in the U.S. Read more here. The post [Lemonade in CTech] These Are The Biggest Israeli Tech Funding Rounds We Reported on in 2019 appeared first on OurCrowd.

support 36
article thumbnail

Monetizing Analytics Features

Think your customers will pay more for data visualizations in your application? Five years ago, they may have. But today, dashboards and visualizations have become table stakes. Turning analytics into a source of revenue means integrating advanced features in unique, hard-to-steal ways. Download this white paper to discover which features will differentiate your application and maximize the ROI of your analytics.